3-Morpholinopyridin-4-amine
|
- $350 - $3993
- Product name: 3-Morpholinopyridin-4-amine
- CAS: 144864-28-8
- MF: C9H13N3O
- MW: 179.22
- EINECS:
- MDL Number:MFCD20715635
- Synonyms:3-Morpholinopyridin-4-amine;3-(morpholin-4-yl)pyridin-4-amine;4-AMINO-3-(MORPHOLINO)PYRIDINE;4-Pyridinamine, 3-(4-morpholinyl)-
5 prices
Selected condition：
Brand
- AK Scientific
- Crysdot
- TRC
Package
- 100mg
- 1g
- 5g
- 10g
- ManufacturerAK Scientific
- Product number2345DX
- Product description3-Morpholinopyridin-4-amine
- Packaging100mg
- Price$413
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number2345DX
- Product description3-Morpholinopyridin-4-amine
- Packaging5g
- Price$2725
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number2345DX
- Product description3-Morpholinopyridin-4-amine
- Packaging10g
- Price$3993
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11254352
- Product description3-Morpholinopyridin-4-amine 97%
- Packaging1g
- Price$548
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM732963
- Product description3-Morpholinopyridin-4-amine
- Packaging100mg
- Price$350
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 2345DX | 3-Morpholinopyridin-4-amine | 100mg | $413 | 2021-12-16 | Buy |
| AK Scientific | 2345DX | 3-Morpholinopyridin-4-amine | 5g | $2725 | 2021-12-16 | Buy |
| AK Scientific | 2345DX | 3-Morpholinopyridin-4-amine | 10g | $3993 | 2021-12-16 | Buy |
| Crysdot | CD11254352 | 3-Morpholinopyridin-4-amine 97% | 1g | $548 | 2021-12-16 | Buy |
| TRC | M732963 | 3-Morpholinopyridin-4-amine | 100mg | $350 | 2021-12-16 | Buy |
Properties
Boiling point :388.1±42.0 °C(Predicted)
Density :1.208±0.06 g/cm3(Predicted)
pka :9.79±0.18(Predicted)
Density :1.208±0.06 g/cm3(Predicted)
pka :9.79±0.18(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|